Why consider Germany for immunotherapy for lung cancer?
Access advanced Immunotherapy for lung cancer solutions in trusted clinics .
The cost of immunotherapy for lung cancer in Germany typically ranges from $50,000 to $100,000. Prices can vary depending on the type of immunotherapy (such as PD-1/PD-L1 inhibitors), the number of treatment cycles, the clinic, and the patient’s overall health. In the United States, the average cost is $90,000 (per NCCN guidelines). That means immunotherapy in Germany can be about _price_percent_discount_% less expensive than in the U.S.
German hospitals usually include the initial consultation, diagnostic tests, medication (such as pembrolizumab or nivolumab), infusion sessions, and follow-up visits in the price. In the U.S., costs often cover only the drug itself, with extra charges for hospital administration, labs, and follow-ups. Always confirm exactly what’s included with each German clinic before starting treatment.
| Germany | Turkey | Austria | |
| Immunotherapy for lung cancer | from $50,000 | from $18,000 | from $30,000 |
No hidden fees – just official clinic prices. Pay at the clinic for Immunotherapy for lung cancer upon arrival and use a flexible installment plan if needed.
Bookimed is committed to your safety. We only work with medical institutions that maintain high international standards in Immunotherapy for lung cancer and have the necessary licenses to serve international patients worldwide.
Bookimed offers free expert assistance. A personal medical coordinator supports you before, during, and after your treatment, solving any issues. You're never alone on your Immunotherapy for lung cancer journey.
Nordwest Krankenhaus is a multi specialized medical institution, a leading hospital in Germany due to development of innovations, such as 3D ultrasound, anticancer vaccines in targeted therapy. It comprises 5 research institutes and 11 specialized centers.
Asklepios Hospital Barmbek is a clinic No. 1 for foreign patients according to the Medical Travel Quality Alliance, the international organization for medical tourism.
The Hospital is a multidisciplinary medical center. It is a part of Asklepios Kliniken, the most significant German hospitals' network.
Asklepios Barmbek specializes in Oncology, Oncohematology, Surgery, and Pulmonology.
80,000 patients from Germany and other countries worldwide receive treatment annually here.
Asklepios Nord is the largest multidisciplinary hospital in Hamburg. It is included in the biggest medical network in Germany — Asklepios Kliniken.
Pediatrics, neurosurgery, gastroenterology, ophthalmology, maxillofacial surgery are the main specialties at Asklepios Nord.
Asklepios Nord is regularly ranked among TOP hospitals in Germany for dentistry, ophthalmology, proctology.
72,000 patients receive treatment in the hospital annually.
Klinikum Bremen-Ost is a multidisciplinary hospital located in Bremen. The hospital is a part of the Gesundheit Nord-Klinikverbund Bremen network of hospitals. Bremen-Ost Hospital specializes in lung surgery, neurology, psychotherapy, and psychiatry.
Bremen-Ost is among best German medical facilities in 2015-2016 according to the rating of Focus magazine. The rating includes hospitals with positive patients’ feedback and high treatment success rates.
Every year Bremen-Ost receives 19,000 patients for treatment.
Day 1 - Arrival
Day 2 - Pre-operation
Day 3 - Immunotherapy
Day 4 - Post-operation
Week 1 - Rehabilitation
Week 2 - Rehabilitation
Please keep in mind that each patient"s journey is unique and can vary. Always follow the specific advice provided by your medical team.
What patients like:
What patients don’t like:
Dr. Viola Fox is the Chief Physician at the Clinic for Haematology, Oncology, and Palliative Medicine at BKZ Solingen. This clinic is a certified interdisciplinary cancer center. Dr. Fox is a leading expert in drug therapy for tumor diseases in Germany and Europe. She has more than 15 years of experience in this field.
She is a member of the German Society of Oncology and Haemato-oncology (GDHO), the German Association of Physicians, and the American Association for Cancer Research. Dr. Fox is also active in molecular biology research. Her work supports progress in cancer treatment and molecular diagnostics.
Her main areas of expertise are chemotherapy, immunotherapy, targeted therapy, and radiation therapy. Dr. Fox is known for her innovative methods and strong commitment to patient care. Her efforts have led to high recovery rates and recognition from her peers.